Insider trade

Labcorp (LH)Director sold ~$241K

Dwight Gary Gilliland, Director at Labcorp, sold ~$241K of Labcorp shares.

~$241K
Approx. value · 1,000 sh @ $241.00
7,712
Holds after · shares reported
Traded
Dec 2, 2024
Filed
Dec 4, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 24, 2024InsiderDirector sold ~$230K of LH shares in the open market
  2. Nov 11, 2024InsiderCEO sold ~$1.51M of LH shares in the open market
  3. Nov 21, 2024InsiderOfficer sold ~$239K of LH shares in the open market
  4. Nov 22, 2024InsiderOfficer sold ~$877K of LH shares in the open market
  5. Dec 2, 2024 · this disclosureInsiderDirector sold ~$241K of LH shares in the open market

What came next

  1. Dec 2, 2024InsiderOfficer sold ~$2.82M of LH shares in the open market
  2. Jan 7, 2025InsiderDirector sold ~$235K of LH shares in the open market
  3. Feb 5, 2025CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  4. Feb 8, 2025CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  5. Feb 11, 2025InsiderCEO sold ~$1.5M of LH shares in the open market
  6. Feb 17, 2025CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  7. Feb 18, 2025InsiderOfficer sold ~$348K of LH shares in the open market
  8. Feb 24, 2025InsiderOfficer sold ~$57K of LH shares in the open market
  9. Feb 25, 2025InsiderOfficer sold ~$330K of LH shares in the open market
  10. Feb 25, 2025CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  11. Feb 27, 2025CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  12. Feb 28, 2025InsiderOfficer sold ~$1.33M of LH shares in the open market
  13. Feb 28, 2025CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  14. Mar 5, 2025InsiderDirector sold ~$128K of LH shares in the open market
  15. Mar 28, 2025Insider · 2 peopleInsiders: 2 sales (~$786K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Labcorp

For Labcorp, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 5 Congress trade reports and 13 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LH page.

Other recent filings by Dwight Gary Gilliland, Director

The full history of Dwight Gary Gilliland, Director is on the profile page.

How this filing works

Other disclosures at Labcorp

Everything OQRO holds on this company is on its LH page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data